### Comment:
Not sure about AMRN (just got it because WSB was raving about it) but I’m pretty sure CRISPR has the potential to easily be at +150% or more in 5 years, which are exactly the types of stocks I’m trying to get at. At least for the “growth” half

### REPLY:
CRSPR as well as any gene editing company that uses CRSPR.  I’m in AMRN the expanded label on their drug will make it bigger than Lipitor.

### END.